Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity.
Dasgupta
Ranan
R
D018723:Bethanechol / Q000627:therapeutic use*; D018679:Cholinergic Agonists / Q000627:therapeutic use*; D015232:Dinoprostone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004594:Electrophysiology; D005260:Female; D006801:Humans; D001743:Urinary Bladder / Q000187:drug effects; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D016055:Urinary Retention / Q000188:drug therapy
D018679:Cholinergic Agonists; D018723:Bethanechol; D015232:Dinoprostone